Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson’s Progression Markers Initiative

Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson’s Progression Markers Initiative
PPMI is a landmark study sponsored by The Michael J. Fox Foundation to better understand Parkinson's disease and accelerate the development of new treatments. 4D pharma representatives will contribute ... read more
Source: Bing NewsPublished on 2020-12-21